Download PDF
Thorac Cardiovasc Surg 2003; 51(5): 283-287
DOI: 10.1055/s-2003-43089
Original Thoracic
Original Cardiovascular
© Georg Thieme Verlag Stuttgart · New York

Distant Failure after Treatment of Postoperative Locoregional Recurrence of Non-Small Cell Lung Cancer

K.  Hotta1 , I.  Sekine1 , K.  Suzuki2 , H.  Kondo2 , H.  Asamura2 , M.  Sumi3 , N.  Yamamoto1 , H.  Kunitoh1 , Y.  Ohe1 , T.  Tamura1 , T.  Kodama1 , N.  Saijo1 , R.  Tsuchiya2
  • 1Division of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
  • 2Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan
  • 3Division of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan
Further Information

Publication History

Received January 1, 2003

Publication Date:
22 October 2003 (online)

    Permissions and Reprints All articles of this category

Abstract

Background: The standard treatment for patients with locoregional recurrence of non-small cell lung cancer (NSCLC) after complete resection has not been established. The aim of this study was to evaluate clinicopathologic characteristics, type of locoregional recurrence, pattern of subsequent failure, and survival after the recurrence. Methods: Of 743 patients undergoing pulmonary resection for NSCLC in the National Cancer Center Hospital between 1990 and 1995, we retrospectively reviewed the medical charts of the 43 patients (5.8 %) found to have locoregional recurrence without distant metastasis or pleural or pericardial involvement. Results: The median time to locoregional recurrence was 13.6 months (range: 1.6 - 85.8 months). The most frequent site of recurrence was the mediastinal nodes in 21 of 43 patients (49 %). 33 patients (77 %) received further treatment for the recurrence: thoracic irradiation in 26, surgery in two, systemic chemotherapy in two, and a combination of the above in 3 patients. Subsequent distant failure was detected in 26 (68 %) of the 38 patients assessable for the analysis of failure pattern: lung in 11, brain in 6, bone in 5, and others in 13. The median interval from the recurrence to distant failure was 8.4 months (range: 1.7 - 56.4 months). The median survival time after diagnosis of the locoregional recurrence was 10.5 months (range: 0 - 74.0 months). A multivariate analysis showed that local therapy for the locoregional recurrence had no significant impact on postrecurrent survival or distant failure-free survival. Conclusions: Many patients with postoperative locoregional recurrence developed distant metastases early after the first recurrence. Systemic chemotherapy in addition to local therapy may be of benefit in this population.

Key words

Non-small cell lung cancer - postoperative locoregional recurrence - local therapy - distant failure

References

  • 1 Pairolero P C, Williams D E, Bergstralh E J, Piehler J M, Bernatz P E, Payne W S. Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease.  Ann Thorac Surg. 1984;  38 331-338
    CrossrefPubMedGoogle Scholar
  • 2 Harpole D H , Herndon J E , Young W G , Wolfe W G, Sabiston D C . A multivariate analysis of treatment methods and patterns of recurrence.  Cancer. 1995;  76 787-796
    CrossrefPubMedGoogle Scholar
  • 3 Cangemi V, Volpino P, D’Andrea N. et al . Local and/or distant recurrences in T1 - 2/N0 - 1 non-small cell lung cancer.  Eur J Cardiothorac Surg. 1995;  9 473-478
    CrossrefPubMedGoogle Scholar
  • 4 Martini N, Bains M S, Burt M E. et al . Incidence of local recurrence and second primary tumors in resected stage I lung cancer.  J Thorac Cardiovasc Surg. 1995;  109 120-129
    CrossrefPubMedGoogle Scholar
  • 5 Yano T, Hara N, Ichinose Y. et al . Local recurrence after complete resection for non-small cell carcinoma of the lung.  J Thorac Cardiovasc Surg. 1994;  107 8-12
    PubMedGoogle Scholar
  • 6 Sawyer T E, Bonner J A, Gould P M, Deschamps C, Lange C M, Li H. Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: Implications related to the design of clinical trials.  Int J Radiat Oncol Biol Phys. 1999;  45 315-321
    PubMedGoogle Scholar
  • 7 Kotlyarov E V, Rukosuyev A A. Long-term results and patterns of disease recurrence after radical operations for lung cancer.  J Thorac Cardiovasc Surg. 1991;  102 24-28
    PubMedGoogle Scholar
  • 8 Green N, Kern W. The clinical course and treatment results of patients with postresection locally recurrent lung cancer.  Cancer. 1978;  42 2478-2482
    PubMedGoogle Scholar
  • 9 Curran W J, Herbert S H, Stafford P M. et al . Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?.  Int J Radiat Oncol Biol Phys. 1992;  24 25-30
    PubMedGoogle Scholar
  • 10 Leung J, Ball D, Worotniuk T, Laidlaw C. Survival following radiotherapy for post-surgical locoregional recurrence of non-small cell lung cancer.  Lung cancer. 1995;  13 121-127
    CrossrefPubMedGoogle Scholar
  • 11 Kagami Y, Nishio M, Narimatsu N. et al . Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancer.  Lung cancer. 1998;  20 31-35
    CrossrefPubMedGoogle Scholar
  • 12 Jeremic B, Shibamoto Y, Milicic B. et al . External beam radiation therapy alone for loco-regional recurrence of non-small cell lung cancer after complete resection.  Lung cancer. 1999;  23 135-142
    CrossrefPubMedGoogle Scholar
  • 13 Shaw E G, Brindle J S, Creagan E T, Foote R L, Trastek V F, Buskirk S J. Locally recurrent non-small cell lung cancer after complete surgical resection.  Mayo Clin Proc. 1992;  67 1129-1133
    PubMedGoogle Scholar
  • 14 Emami B, Graham M V, Deedy M, Shapiro S, Kucik N. Radiation therapy for intrathoracic recurrence of non-small cell lung cancer.  Am J Clin Oncol. 1997;  20 46-50
    CrossrefPubMedGoogle Scholar
  • 15 Perez C A, Pajak T F, Rubin P. et al . Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy.  Cancer. 1987;  59 1874-1881
    CrossrefPubMedGoogle Scholar
  • 16 Le Chevalier T, Arriagada R, Quoix E. et al . Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients.  J Natl Cancer Inst. 1991;  83 417-423
    CrossrefPubMedGoogle Scholar
  • 17 Dillman R O, Herndon J, Seagren S L, Eaton W L, Green M R. Improved survival of stage III non-small-cell lung cancer: Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial.  J Natl Cancer Inst. 1996;  88 1210-1215
    CrossrefPubMedGoogle Scholar
  • 18 Sause W T, Scott C, Taylor S. et al . Radiation Therapy Oncology Group (RTOG) 88 - 08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.  J Natl Cancer Inst. 1995;  87 198-205
    PubMedGoogle Scholar

Katsuyuki Hotta, MD 

Department of Internal Medicine II, Okayama University Medical School

2-5-1, Shitaka-cho, Okayama

700-8558, Japan

Phone: +81-86-235-7227

Fax: +81-86-232-8226

Email: khotta@md.okayama-u.ac.jp

      >